2022
DOI: 10.1021/acs.chemrestox.2c00054
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic Activation of Gemfibrozil Mediated by Cytochrome P450 Enzymes and Sulfotransferases

Abstract: Gemfibrozil (GEM), a lipid regulator, is a fibric acid derivative widely used in the treatment of hyperlipidemia. It has been reported that GEM can induce acute liver injury in the course of therapy in clinical practice, so it is necessary to elucidate the mechanisms of toxic action. The present study focused on metabolic activation of GEM, possibly participating in GEM-mediated liver injury. A benzylic alcohol metabolite (M1), along with a phenol metabolite (M2), was detected in microsomal incubations, rat pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 33 publications
(48 reference statements)
1
6
0
Order By: Relevance
“…aryl substructures, being risky for RM formation, which we have been able to compile should serve as an argument for increasing our limited understanding by collecting more basic quantitative data. In support of our observations, new examples (Chart 4) are being added at a steady rate: gemfibrozil forms an alkylating sulfate (Picture S11), 126 and the established drug metoprolol (154, Chart 4) was recently reported to form a methide that might explain the exceedingly rare cases of induced liver injury. 127 Several other drugs, for example zolpidem (151, Chart 4), have a structural setup for forming an arylmethanol but have not been studied so far.…”
Section: Discussionsupporting
confidence: 72%
See 1 more Smart Citation
“…aryl substructures, being risky for RM formation, which we have been able to compile should serve as an argument for increasing our limited understanding by collecting more basic quantitative data. In support of our observations, new examples (Chart 4) are being added at a steady rate: gemfibrozil forms an alkylating sulfate (Picture S11), 126 and the established drug metoprolol (154, Chart 4) was recently reported to form a methide that might explain the exceedingly rare cases of induced liver injury. 127 Several other drugs, for example zolpidem (151, Chart 4), have a structural setup for forming an arylmethanol but have not been studied so far.…”
Section: Discussionsupporting
confidence: 72%
“…As recently reported, gemfibrozil in parallel forms a benzylic alcohol, which is sulfated and forms a GSH adduct (Picture S11). 126…”
Section: Discussionmentioning
confidence: 99%
“…Metabolites were also analyzed by an AB SCIEX 4000 Q-trap coupled to a UPLC system. Further analyses were carried out using similar procedures, as described in our publication . In addition, a high-resolution mass spectrometer (micro Q-TOF, Bruker, Germany) was used to analyze the synthetic products (M7 and M8).…”
Section: Methodsmentioning
confidence: 99%
“…Further analyses were carried out using similar procedures, as described in our publication. 27 In addition, a high-resolution mass spectrometer (micro Q-TOF, Bruker, Germany) was used to analyze the synthetic products (M7 and M8). Data were processed using Bruker Daltonics Data Analysis 3.4 software.…”
Section: Microsomal Incubation Inhibition Experimentsmentioning
confidence: 99%
“…41 This drug is primarily used to treat individuals with Type IV and Type V hyperlipidemia who are at risk of developing cardiovascular ailments, coronary vascular issues, and other lipid-associated conditions. 38,42 Gem is ingested orally in tablet form, with a recommended dosage of approximately 20 mg/kg. 43 Each tablet contains 600 mg of Gem and is taken with water.…”
Section: Overvie W Of G Emfib Rozilmentioning
confidence: 99%